Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,266,934 | 2,266,934 | 0 | $55.54M | $56.22M | 75.61% | +$680.1K |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $27.82M | $12.90M | 17.35% | -$14.92M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $6.94M | $5.23M | 7.04% | -$1.70M |